Model Details

Patient Information for Model: BCM-PDAC-11

Patient Information
Clinical Timeline


Clinical Information at Collection
Clinical Biomarkers/Mutations at Collection
Pathology Information at Collection

Model Information for Model: BCM-PDAC-11

Model Details
Mutations
There are no omics data for this model.

CNV


Metastasis Information for Model: BCM-PDAC-11
 
Patient
PDX
Liver
Local recurrence
Lung
Rectum
lymph node

Patient Treatment Information for Model: BCM-PDAC-11

Event IdTreatmentTreatment SettingAge at StartAge at EndDurationClinical ResponseReason Stopped
25Gemcitabine Adjuvant60.1760.6157 daysNo evidence of diseaseTreatment completed
30FolfirinoxAdjuvant60.9961.0729 daysSide Effects
35Folfox Adjuvant61.1361.2336 daysStable Disease (SD)Treatment completed
40Capecitabine/radiation Adjuvant61.361.437 daysStable Disease (SD)Treatment completed
45CapecitabineAdjuvant61.5161.7380 daysProgressive Disease (PD)Stopped due to disease progression
50Gemcitabine/AbraxaneAdjuvant61.861.8518 daysProgressive Disease (PD)Disease progression and clinical decompensation












Timeout
Your session is about to expire. Click 'Stay Connected' to continue the session.